Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[Webinar held in August] Automatic sorting of huge amount of medical information in the company using AI-Introduction of Mekiki that realizes operational efficiency-

In addition to handling medical specialty information based on strict standards in operations such as clinical development, regulatory application, and quality control, pharmaceutical companies provide supervision and guidance on promotional activities in accordance with the "Guidelines for Providing Sales Information for Prescription Drugs." We spend a lot of effort and money on document management and examination work.
In this seminar, we will introduce "Mekiki", a system that automatically sorts medical / medical specialized information using FRONTEO's original natural language analysis AI engine "Concept Encoder". In "Mekiki", AI automatically extracts the texts that should be examined, and realizes significant operational efficiency.
 
 

【Webinar Summary】

◆ Title: Automatic sorting of huge amount of medical information in the company using AI-Introduction of Mekiki that realizes operational efficiency-
◆ Date: July 2021, 8 (Tuesday) 31: 11-00: 11
◆ Recommended for people like this!
・ Those who work for a pharmaceutical company
・ Those who want to reduce the cost of document management and document review
・ Those who want to improve work efficiency by utilizing AI
 
 

 
Speakers/panelist:
 
Yuu Kanazawa(FRONTEO Life Science AI Business Headquarters)
 
Joined Sumitomo Dainippon Pharma Co., Ltd. as an MR in 2010.Regarding the primary area Sales from core hospitals in Tokyo to small and medium-sized clinics / individual practitioners We conduct sales activities centered on practitioners in Tokyo. Joined Eli Lilly Japan K.K. in 2015 and engaged in oncology, mainly in university hospitals and related facilities.
At FRONTEO, we are engaged in DX business promotion and new business development activities using AI for various companies including pharmaceutical companies.
 
Share this article